Quick Answer
STAAR SURGICAL CO reported Research And Development Expense of $40.06 million for the year ending 2025.
- STAAR SURGICAL CO showed a decrease of -11.6% in Research And Development Expense from 2024 to 2025.
- This data is from STAAR SURGICAL CO's annual report (Form 10-K), filed with the SEC on March 3, 2026.
- XBRL data for this metric is available from 2009 to 2025 (17 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Over the full 17 years of available data (2009 to 2025), STAAR SURGICAL CO's Research And Development Expense has grown by 579.7%.
- Historical annual values: Fiscal year 2025: $40.06 million | Fiscal year 2024: $45.32 million | Fiscal year 2023: $40.48 million | Fiscal year 2022: $35.98 million | Fiscal year 2021: $33.86 million | Fiscal year 2020: $31.92 million | Fiscal year 2019: $25.30 million | Fiscal year 2018: $22.03 million | Fiscal year 2017: $20.04 million | Fiscal year 2016: $20.67 million | Fiscal year 2015: $14.76 million | Fiscal year 2014: $12.36 million | Fiscal year 2013: $6.71 million | Fiscal year 2012: $6.44 million | Fiscal year 2011: $5.87 million | Fiscal year 2010: $5.72 million | Fiscal year 2009: $5.89 million.
- Data sourced from SEC EDGAR public filings as of June 20, 2026.
Last verified: